• Roots Analysis is pleased to announce the publication of its recent study, titled, “In Vitro ADME Testing Services Market, 2019-2030”

    The report features an extensive study on the current landscape and the likely future potential of the companies offering in vitro ADME services. The study features an in-depth analysis, highlighting the capabilities of various industry stakeholders. In addition to other elements, the report includes:
     A detailed assessment of the current landscape, of companies offering in vitro ADEM testing services.
     A schematic logo landscape of in vitro ADME service providers, highlighting their geographical distribution (on the basis of location of headquarters) and company size.
     A discussion on the various outsourcing business models used in this domain, along with a list of key considerations that need to be taken into account by industry stakeholders while selecting a CRO partner.
     Elaborate profiles of popular players that offer a wide range of in vitro ADME testing services (shortlisted on the basis of the company size).
     A detailed peer group-based benchmarking analysis, comparing the involved players based on several relevant parameters related to company and services.
     A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2005-2018
     A discussion on the various regulatory guidelines related to in vitro ADME testing, which have been laid down by major international / regional regulatory bodies.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

    To request for sample report – https://www.rootsanalysis.com/reports/239/request-sample.html

     Type of Molecule
     Small Molecules
     Biologics

     Type of Service
     Absorption Testing
     Distribution Testing
     Metabolism and Elimination Testing

     Type of Assay
     Caco-2 Permeability Assay
     PAMPA Permeability Assay
     MDCK Permeability Assay
     Protein Binding Assay
     Blood Brain Barrier Assay
     Blood to Plasma Ratio
     Stability / Clearance Assay
     Enzyme Induction Assay
     Enzyme Inhibition Assay
     Metabolite Profiling and Screening / Identification Assay
     Metabolite Production Assay
     Reaction Phenotyping Assay
     Transporter Interactions Assay

     Target Therapeutic Area
     Blood Disorders
     Cardiovascular Disorders
     Gastrointestinal and Digestive Disorders
     Hormonal Disorders
     Infectious Diseases
     Immunological Disorders
     Metabolic Disorders
     Mental Disorders
     Neurological Disorders
     Oncological Disorders
     Respiratory Disorders
     Skin Disorders
     Urogenital Disorders
     Others

    To request for customize report - https://www.rootsanalysis.com/reports/239/request-sample.html

     Type of Sponsor
     Industry Players
     Non-Industry Players

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific and Rest of the World

    Key companies covered in the report
     Albany Molecular Research (AMRI)
     Charles River Laboratories
     Pharmaceutical Product Development (PPD)
     RTI International
     Eurofins Scientific
     Evotec
     Galapagos
     Tecan Group
     GVK Biosciences
     Pharmaron
     Sai Life Sciences
     Shanghai Medicilon
     WuXi AppTec

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/in-vitro-adme-testing-services-market-2019-2030/239.html

    Other Recent Offerings
    1. In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules, 2020-2030
    2. AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030
    3. Bioavailability Enhancement Technologies and Services Market, 2020-2030

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis

    Roots Analysis is pleased to announce the publication of its recent study, titled, “In Vitro ADME Testing Services Market, 2019-2030” The report features an extensive study on the current landscape and the likely future potential of the companies offering in vitro ADME services. The study features an in-depth analysis, highlighting the capabilities of various industry stakeholders. In addition to other elements, the report includes:  A detailed assessment of the current landscape, of companies offering in vitro ADEM testing services.  A schematic logo landscape of in vitro ADME service providers, highlighting their geographical distribution (on the basis of location of headquarters) and company size.  A discussion on the various outsourcing business models used in this domain, along with a list of key considerations that need to be taken into account by industry stakeholders while selecting a CRO partner.  Elaborate profiles of popular players that offer a wide range of in vitro ADME testing services (shortlisted on the basis of the company size).  A detailed peer group-based benchmarking analysis, comparing the involved players based on several relevant parameters related to company and services.  A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2005-2018  A discussion on the various regulatory guidelines related to in vitro ADME testing, which have been laid down by major international / regional regulatory bodies.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) To request for sample report – https://www.rootsanalysis.com/reports/239/request-sample.html  Type of Molecule  Small Molecules  Biologics  Type of Service  Absorption Testing  Distribution Testing  Metabolism and Elimination Testing  Type of Assay  Caco-2 Permeability Assay  PAMPA Permeability Assay  MDCK Permeability Assay  Protein Binding Assay  Blood Brain Barrier Assay  Blood to Plasma Ratio  Stability / Clearance Assay  Enzyme Induction Assay  Enzyme Inhibition Assay  Metabolite Profiling and Screening / Identification Assay  Metabolite Production Assay  Reaction Phenotyping Assay  Transporter Interactions Assay  Target Therapeutic Area  Blood Disorders  Cardiovascular Disorders  Gastrointestinal and Digestive Disorders  Hormonal Disorders  Infectious Diseases  Immunological Disorders  Metabolic Disorders  Mental Disorders  Neurological Disorders  Oncological Disorders  Respiratory Disorders  Skin Disorders  Urogenital Disorders  Others To request for customize report - https://www.rootsanalysis.com/reports/239/request-sample.html  Type of Sponsor  Industry Players  Non-Industry Players  Key Geographical Regions  North America  Europe  Asia-Pacific and Rest of the World Key companies covered in the report  Albany Molecular Research (AMRI)  Charles River Laboratories  Pharmaceutical Product Development (PPD)  RTI International  Eurofins Scientific  Evotec  Galapagos  Tecan Group  GVK Biosciences  Pharmaron  Sai Life Sciences  Shanghai Medicilon  WuXi AppTec For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/in-vitro-adme-testing-services-market-2019-2030/239.html Other Recent Offerings 1. In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules, 2020-2030 2. AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030 3. Bioavailability Enhancement Technologies and Services Market, 2020-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    Request Sample - In Vitro ADME Testing Services Market | Industry Analysis | Market Size | 2030
    Within Asia-Pacific, markets in China and Japan are expected to grow at a relatively faster rate (~11%) in the coming decade.
    0 Comments 0 Shares
  • More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications

    The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago. Presently, a variety of other such chemical entities and molecular glues are under investigation. In fact, certain pipeline candidates are already in the mid to late-phase trials and are anticipated to soon enter the market.

    To order this 330+ page report, which features 130+ figures and 145+ tables, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html

    The USD 3.6 billion (by 2030) financial opportunity within the target protein degradation market has been analyzed across the following segments:
     Type of payment of licensing agreements
     Upfront payments
     Milestone payments

     Type of protein degrader
     Degronimids
     PROTACs
     SARDs / SERDs
     Specific BET and DUB inhibitors
     Other protein degraders

     Therapeutic area
     Neurodegenerative disorders
     Oncological disorders
     Other therapeutic areas

     Route of administration
     Oral
     Intravenous
     Other routes

     Key geographical region
     North America
     Europe
     Asia-Pacific

    The Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030 report features the following companies, which we identified to be key players in this domain:
     Arvinas
     Captor Therapeutics
     Celgene
     Genetech
     Kymera Therapeutics
     Mission Therapeutics
     Progenra
     Radius Health
     Sanofi Genzyme
     Zenopharm

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Current Market Landscape

    5. Company Profiles

    6. Clinical Trial Analysis

    7. KOL Analysis

    8. Publication Analysis

    9. Funding and Investment Analysis

    10. Partnerships and Collaborations

    11. Market Sizing and Opportunity Analysis

    12. Executive Insights

    13. Concluding Remarks

    14. Appendix 1: Tabulated Data

    15. Appendix 2: List of Companies and Organizations

    To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis

    More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago. Presently, a variety of other such chemical entities and molecular glues are under investigation. In fact, certain pipeline candidates are already in the mid to late-phase trials and are anticipated to soon enter the market. To order this 330+ page report, which features 130+ figures and 145+ tables, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html The USD 3.6 billion (by 2030) financial opportunity within the target protein degradation market has been analyzed across the following segments:  Type of payment of licensing agreements  Upfront payments  Milestone payments  Type of protein degrader  Degronimids  PROTACs  SARDs / SERDs  Specific BET and DUB inhibitors  Other protein degraders  Therapeutic area  Neurodegenerative disorders  Oncological disorders  Other therapeutic areas  Route of administration  Oral  Intravenous  Other routes  Key geographical region  North America  Europe  Asia-Pacific The Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030 report features the following companies, which we identified to be key players in this domain:  Arvinas  Captor Therapeutics  Celgene  Genetech  Kymera Therapeutics  Mission Therapeutics  Progenra  Radius Health  Sanofi Genzyme  Zenopharm Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Current Market Landscape 5. Company Profiles 6. Clinical Trial Analysis 7. KOL Analysis 8. Publication Analysis 9. Funding and Investment Analysis 10. Partnerships and Collaborations 11. Market Sizing and Opportunity Analysis 12. Executive Insights 13. Concluding Remarks 14. Appendix 1: Tabulated Data 15. Appendix 2: List of Companies and Organizations To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    WWW.ROOTSANALYSIS.COM
    Targeted Protein Degradation Market | Industry Analysis | Market Size | 2030
    Research report on the future opportunity of targeted protein degradation therapeutics and technology platforms
    0 Comments 0 Shares
  • The Rapidly Growing E-Bikes Industry: Popular Trends And Impact Of Covid19

    The electric bike market is huge in the industry; you can say that it is billion dollars market; many countries governments support and help in a positive impact of Covid-19 pandemic on sales of e-bikes will drive the e-bike market differently, basically, the government trying to boost the market of e-bikes after the pandemic. Last year government proudly witnesses the e-bike market with a huge increase in e-bikes sales. As per the survey, Asia Pacific is the largest market for e-bikes during the pandemic period. In this region, Japan, Korea, India and Taiwan are trustworthy markets in owing and give their best to increase the sale of e-bike.

    Read here: https://www.pressroom.biz/@dirodi/the-rapidly-growing-e-bikes-industry-popular-trends-and-impact-of-covid19-w3d7pn8nj7k5

    #EbikeOnline
    #ElectricFatBike
    #ElectricFatBikeAustralia
    The Rapidly Growing E-Bikes Industry: Popular Trends And Impact Of Covid19 The electric bike market is huge in the industry; you can say that it is billion dollars market; many countries governments support and help in a positive impact of Covid-19 pandemic on sales of e-bikes will drive the e-bike market differently, basically, the government trying to boost the market of e-bikes after the pandemic. Last year government proudly witnesses the e-bike market with a huge increase in e-bikes sales. As per the survey, Asia Pacific is the largest market for e-bikes during the pandemic period. In this region, Japan, Korea, India and Taiwan are trustworthy markets in owing and give their best to increase the sale of e-bike. Read here: https://www.pressroom.biz/@dirodi/the-rapidly-growing-e-bikes-industry-popular-trends-and-impact-of-covid19-w3d7pn8nj7k5 #EbikeOnline #ElectricFatBike #ElectricFatBikeAustralia
    0 Comments 0 Shares
  • The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis

    Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.”

    The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of BBB penetration technologies and affiliated drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:
     An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters
     A detailed assessment of the current market landscape of BBB penetrant drugs.
     Identification of contemporary market trends, depicted using three schematic representations, which include [A] a tree map representation, [B] a bubble analysis and [C] an informative heptagon representation.
     An insightful competitiveness analysis of BBB penetration technologies, taking into consideration the supplier power and key technology specific information.
     Elaborate profiles of prominent technology developers that are engaged in the development of at least four drugs.
     An analysis of the partnerships that have been established in the domain, in the period between 2014 and 2020.
     An elaborate discussion on the deal structures of various types of technology licensing agreements inked in this domain.
     An analysis of the investments made in the domain, in the period between 2014 and 2020 (till March).
     An in-depth analysis of the various patents that have been filed / granted related to BBB penetration technologies, till November 2019.
     An insightful chessboard analysis highlighting the most preferred / popular drug development strategies / paths adopted by majority of the drug developers (with clinical candidates) in order to progress their lead drug candidates.
     An assessment of the most commonly targeted disorders affecting the CNS, shortlisted on the basis of number of BBB penetrant drugs in development.
     A list of 240+ drug developers targeting Alzheimer’s disease and Parkinson’s disease that are likely to partner with BBB penetration technology providers.
     A case study highlighting the working principle of the most common approaches that are being employed for the development of BBB penetration technologies.
     An informative analysis of contemporary Google Trends in the time period between 2015 and 2019 (till December) and insights generated from recent news articles related to the BBB, indicating the increasing popularity of this domain.
    A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) :
     Type of Payment Model Adopted
     Upfront payments
     Milestone payments

     Type of Molecule
     Small Molecules
     Biologics

     Target Disease Indication
     Brain Metastases in Breast Cancer
     Glioblastoma Multiforme
     Hunter Syndrome
     Hurler Syndrome

     Leading Technology Platforms
     G®-Technology
     J-Brain Cargo® Technology
     LRP-1 Technology
     Trojan Horse Technology

     Leading Drug Developers
     2-BBB
     Angiochem
     ArmaGen
     JCR Pharmaceuticals

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific


    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of BBB penetration technologies and affiliated drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:  An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters  A detailed assessment of the current market landscape of BBB penetrant drugs.  Identification of contemporary market trends, depicted using three schematic representations, which include [A] a tree map representation, [B] a bubble analysis and [C] an informative heptagon representation.  An insightful competitiveness analysis of BBB penetration technologies, taking into consideration the supplier power and key technology specific information.  Elaborate profiles of prominent technology developers that are engaged in the development of at least four drugs.  An analysis of the partnerships that have been established in the domain, in the period between 2014 and 2020.  An elaborate discussion on the deal structures of various types of technology licensing agreements inked in this domain.  An analysis of the investments made in the domain, in the period between 2014 and 2020 (till March).  An in-depth analysis of the various patents that have been filed / granted related to BBB penetration technologies, till November 2019.  An insightful chessboard analysis highlighting the most preferred / popular drug development strategies / paths adopted by majority of the drug developers (with clinical candidates) in order to progress their lead drug candidates.  An assessment of the most commonly targeted disorders affecting the CNS, shortlisted on the basis of number of BBB penetrant drugs in development.  A list of 240+ drug developers targeting Alzheimer’s disease and Parkinson’s disease that are likely to partner with BBB penetration technology providers.  A case study highlighting the working principle of the most common approaches that are being employed for the development of BBB penetration technologies.  An informative analysis of contemporary Google Trends in the time period between 2015 and 2019 (till December) and insights generated from recent news articles related to the BBB, indicating the increasing popularity of this domain. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) :  Type of Payment Model Adopted  Upfront payments  Milestone payments  Type of Molecule  Small Molecules  Biologics  Target Disease Indication  Brain Metastases in Breast Cancer  Glioblastoma Multiforme  Hunter Syndrome  Hurler Syndrome  Leading Technology Platforms  G®-Technology  J-Brain Cargo® Technology  LRP-1 Technology  Trojan Horse Technology  Leading Drug Developers  2-BBB  Angiochem  ArmaGen  JCR Pharmaceuticals  Key Geographical Regions  North America  Europe  Asia-Pacific Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    WWW.ROOTSANALYSIS.COM
    Blood-Brain Barrier (BBB) | Industry Analysis | Market Size | 2030
    Blood-Brain Barrier (BBB) Market, 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics Nanoparticle based Approaches)
    0 Comments 0 Shares
  • The prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030, predicts Roots Analysis
    The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringe Fill / Finish Services Market, 2020-2030.”

    The report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes. The study features an in-depth analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:
     A detailed review of the overall landscape of companies offering contract fill / finish services for prefilled syringes
     Tabulated profiles of key players (shortlisted based on a proprietary criterion) across key geographies, such as North America, Europe and Asia-Pacific.
     An analysis of the recent developments (since 2015) pertaining to contract fill / finish services, based on various parameters
     An estimate of the global, contract fill / finish capacity of prefilled syringes, by taking into consideration the capacities of various fill / finish service providers (as available on respective company websites), collected via secondary and primary research.
     An informed estimate of the annual demand for fill / finish of prefilled syringes (in number of units), taking into account the marketed drugs available in prefilled syringes and other relevant parameters, such as target patient population, dosing frequency and dose strength.
     A detailed demand and supply assessment of geographies in this domain.
     An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe fill / finish service providers.
     A discussion on the potential growth areas in this domain.
     A review of the landscape of prefilled syringe manufacturers.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Scale of Operation
     Preclinical / Clinical
     Commercial
     Type of Drug Molecule
     Biologic
     Small Molecule
     Target Therapeutic Area
     Blood Disorders
     Infectious Diseases
     Metabolic Disorders
     Oncological Disorders
     Neurological Disorders
     Autoimmune Disorders
     Others
     Syringe Barrel Material
     Glass
     Plastic
     Number of Barrel Chambers
     Single Chamber
     Dual Chamber
     Key Geographical Region
     North America
     Europe
     Latin America
     Asia-Pacific
     Middle East and Africa

    Key companies covered in the report
     Ajinomoto Bio-Pharma Services
     AMRI
     BioPharma Solutions
     Emergent BioSolutions
     Patheon
     Consort Medical
     EVER Pharma
     GlaxoSmithKline
     IDT Biologika
     Rentschler Biopharma
     Siegfried
     Vetter Pharma
     Biocon
     Intas Pharmaceuticals
     Kemwell Biopharma
     Square Pharmaceuticals

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

    Other Recent Offerings
    1. Prefilled Syringes Market (5th Edition), 2020-2030
    2. Biologics Fill / Finish Services Market, 2019-2030


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis

    The prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030, predicts Roots Analysis The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations Roots Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringe Fill / Finish Services Market, 2020-2030.” The report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes. The study features an in-depth analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:  A detailed review of the overall landscape of companies offering contract fill / finish services for prefilled syringes  Tabulated profiles of key players (shortlisted based on a proprietary criterion) across key geographies, such as North America, Europe and Asia-Pacific.  An analysis of the recent developments (since 2015) pertaining to contract fill / finish services, based on various parameters  An estimate of the global, contract fill / finish capacity of prefilled syringes, by taking into consideration the capacities of various fill / finish service providers (as available on respective company websites), collected via secondary and primary research.  An informed estimate of the annual demand for fill / finish of prefilled syringes (in number of units), taking into account the marketed drugs available in prefilled syringes and other relevant parameters, such as target patient population, dosing frequency and dose strength.  A detailed demand and supply assessment of geographies in this domain.  An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe fill / finish service providers.  A discussion on the potential growth areas in this domain.  A review of the landscape of prefilled syringe manufacturers.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Scale of Operation  Preclinical / Clinical  Commercial  Type of Drug Molecule  Biologic  Small Molecule  Target Therapeutic Area  Blood Disorders  Infectious Diseases  Metabolic Disorders  Oncological Disorders  Neurological Disorders  Autoimmune Disorders  Others  Syringe Barrel Material  Glass  Plastic  Number of Barrel Chambers  Single Chamber  Dual Chamber  Key Geographical Region  North America  Europe  Latin America  Asia-Pacific  Middle East and Africa Key companies covered in the report  Ajinomoto Bio-Pharma Services  AMRI  BioPharma Solutions  Emergent BioSolutions  Patheon  Consort Medical  EVER Pharma  GlaxoSmithKline  IDT Biologika  Rentschler Biopharma  Siegfried  Vetter Pharma  Biocon  Intas Pharmaceuticals  Kemwell Biopharma  Square Pharmaceuticals For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html Other Recent Offerings 1. Prefilled Syringes Market (5th Edition), 2020-2030 2. Biologics Fill / Finish Services Market, 2019-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    WWW.ROOTSANALYSIS.COM
    Prefilled Syringe Fill / Finish Services | Industry Analysis | Market Size | 2030
    Market research report on prefilled syringe (PFS) fill / finish services; with a focus on current market landscape and future growth opportunities
    0 Comments 0 Shares
  • The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis
    Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030.”

    The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
     A detailed review of the overall landscape of fragment-based drug discovery library and service providers.
     Elaborate profiles of the companies providing libraries and services for fragment-based drug discovery (shortlisted on the basis of the service portfolio and number of fragment screening techniques offered).
     An analysis of the partnerships that have been established in the recent past.
     A detailed analysis on acquisition targets.
     An insightful competitiveness analysis of fragment-based drug discovery library and service providers.
     An analysis highlighting the cost saving potential associated with the use of fragment-based drug discovery approach.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Type of Technique
     X-ray Crystallography
     Nuclear Magnetic Resonance
     Surface Plasmon Resonance
     Other Screening Techniques
     Type of Service
     Library Screening
     Fragment Screening
     Fragment Optimization
     End User
     Industry Players
     Non-Industry Players
     Key Geographical Region
     North America (US and Canada)
     Europe (UK, France, Germany, Spain, Italy, and rest of Europe)
     Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world)

    Key companies covered in the report:
     2bind
     Charles River Laboratories
     ChemAxon
     ComInnex
     Creative Biolabs
     Creative Biostructure
     CRELUX
     Domainex
     Evotec
     Red Glead Discovery
     SARomics Biostructures
     Shanghai ChemPartner
     Sygnature Discovery
     Vernalis Research

    For more information, please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

    Other recent offerings
    1. DNA-Encoded Libraries: Platforms and Services Market
    2. Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028
    3. In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery, Fragment Based Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery, Interface Based Drug Discovery Approaches)

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed review of the overall landscape of fragment-based drug discovery library and service providers.  Elaborate profiles of the companies providing libraries and services for fragment-based drug discovery (shortlisted on the basis of the service portfolio and number of fragment screening techniques offered).  An analysis of the partnerships that have been established in the recent past.  A detailed analysis on acquisition targets.  An insightful competitiveness analysis of fragment-based drug discovery library and service providers.  An analysis highlighting the cost saving potential associated with the use of fragment-based drug discovery approach.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Technique  X-ray Crystallography  Nuclear Magnetic Resonance  Surface Plasmon Resonance  Other Screening Techniques  Type of Service  Library Screening  Fragment Screening  Fragment Optimization  End User  Industry Players  Non-Industry Players  Key Geographical Region  North America (US and Canada)  Europe (UK, France, Germany, Spain, Italy, and rest of Europe)  Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world) Key companies covered in the report:  2bind  Charles River Laboratories  ChemAxon  ComInnex  Creative Biolabs  Creative Biostructure  CRELUX  Domainex  Evotec  Red Glead Discovery  SARomics Biostructures  Shanghai ChemPartner  Sygnature Discovery  Vernalis Research For more information, please click on the following link: https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html Other recent offerings 1. DNA-Encoded Libraries: Platforms and Services Market 2. Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028 3. In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery, Fragment Based Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery, Interface Based Drug Discovery Approaches) About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    WWW.ROOTSANALYSIS.COM
    Fragment-based Drug Discovery Market: Library and Service Providers | Industry Analysis | Market Size | 2030
    Market research report on fragment based drug discovery with a focus on opportunities for library and service providers
    0 Comments 0 Shares
  • How Can UK Entrepreneurs Launch A Super App Like A Gojek Clone?
    How Can UK Entrepreneurs start your business with super app like gojek. Origins and evoluation of on demand multi service gojek clone app in southeast asian market.
    https://www.cubetaxi.com/blog/launch-super-app-like-gojek/
    #applikegojek #gojekcloneapp #GojekClone #gojekclonescript
    How Can UK Entrepreneurs Launch A Super App Like A Gojek Clone? How Can UK Entrepreneurs start your business with super app like gojek. Origins and evoluation of on demand multi service gojek clone app in southeast asian market. https://www.cubetaxi.com/blog/launch-super-app-like-gojek/ #applikegojek #gojekcloneapp #GojekClone #gojekclonescript
    0 Comments 0 Shares
  • Big Gaming Casino Malaysia
    Whether you want to play at a Online casino, test your skill at a poker space, or place some bets on admirable events, we’ve got the information to help you get the most from your money. Whether you're playing Big Gaming Casino, bg fishing master, roulette, or just beating the slot, we’ve produced a number of handy guides, every of which deals with everything from beginner tactics through to more advanced plays. Online gambling has become one of the most exhilarating ways to gamble around, giving you the power to have a spin at a slot machine, or play a hand of poker, where you occur to be More visit us: https://biggamingasia.com/
    Big Gaming Casino Malaysia Whether you want to play at a Online casino, test your skill at a poker space, or place some bets on admirable events, we’ve got the information to help you get the most from your money. Whether you're playing Big Gaming Casino, bg fishing master, roulette, or just beating the slot, we’ve produced a number of handy guides, every of which deals with everything from beginner tactics through to more advanced plays. Online gambling has become one of the most exhilarating ways to gamble around, giving you the power to have a spin at a slot machine, or play a hand of poker, where you occur to be More visit us: https://biggamingasia.com/
    Home
    0 Comments 0 Shares
  • The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis
    Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030.”

    The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
     A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing
     Elaborate profiles of some of the key contract manufacturers active in the pharmaceutical and biopharmaceutical continuous manufacturing market
     An analysis of the various partnerships related to continuous manufacturing, which have been established since 2013
     An analysis of the expansions related to continuous manufacturing, which have been established since 2013
     An estimate of the global, continuous manufacturing capacity, based on the capacities of various industry stakeholders (as available on their respective company websites).
     A study of the various grants that have been awarded to research institutes engaged in projects related to continuous manufacturing, between 2014 and 2019
     An in-depth analysis of the various patents that have been filed / granted related to continuous manufacturing till 2019
     Initiatives taken by the leading pharmaceutical companies (in terms of revenues), covering both partnered as well as in-house projects.
     A review of the companies offering modular facilities / modular cleanrooms
     A case study of the companies offering technologies / equipment
     A case study on the roadmap for the adoption of continuous manufacturing technique
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Purpose of Manufacturing
     In-House
     Contract service
     Scale of Operation
     Commercial
     Preclinical / Clinical
     Type of Continuous Manufacturing related Service
     API Manufacturing
     End Product manufacturing
     Type of Drug Molecule
     Biologic
     Small Molecule
     Type of dosage form
     Solid
     Liquid
     Key Geographical Regions
     North America
     Europe
     Asia Pacific

     Transcripts of interviews held with the following senior level representatives of stakeholder companies
     Andrea Adamo, Founder and Chief Executive Officer, Zaiput Flow technologies
     Bayan Takizawa, Co-Founder and Chief Business Officer, CONTINUUS Pharmaceuticals
     Nick Thomson, Senior Director Chemical Research and Development, Pfizer
     Himanshu Gadgil, Director and Chief Scientific Officer, Enzene Biosciences
     Eric Fang, Chief Scientific Officer, Snapdragon Chemistry)
     Ian Houson, Technical Project Manager, Continuous Manufacturing and Crystallization, University of Strathclyde



    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis

    The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing Roots Analysis is pleased to announce the publication of its recent study, titled, “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030.” The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing  Elaborate profiles of some of the key contract manufacturers active in the pharmaceutical and biopharmaceutical continuous manufacturing market  An analysis of the various partnerships related to continuous manufacturing, which have been established since 2013  An analysis of the expansions related to continuous manufacturing, which have been established since 2013  An estimate of the global, continuous manufacturing capacity, based on the capacities of various industry stakeholders (as available on their respective company websites).  A study of the various grants that have been awarded to research institutes engaged in projects related to continuous manufacturing, between 2014 and 2019  An in-depth analysis of the various patents that have been filed / granted related to continuous manufacturing till 2019  Initiatives taken by the leading pharmaceutical companies (in terms of revenues), covering both partnered as well as in-house projects.  A review of the companies offering modular facilities / modular cleanrooms  A case study of the companies offering technologies / equipment  A case study on the roadmap for the adoption of continuous manufacturing technique  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Purpose of Manufacturing  In-House  Contract service  Scale of Operation  Commercial  Preclinical / Clinical  Type of Continuous Manufacturing related Service  API Manufacturing  End Product manufacturing  Type of Drug Molecule  Biologic  Small Molecule  Type of dosage form  Solid  Liquid  Key Geographical Regions  North America  Europe  Asia Pacific  Transcripts of interviews held with the following senior level representatives of stakeholder companies  Andrea Adamo, Founder and Chief Executive Officer, Zaiput Flow technologies  Bayan Takizawa, Co-Founder and Chief Business Officer, CONTINUUS Pharmaceuticals  Nick Thomson, Senior Director Chemical Research and Development, Pfizer  Himanshu Gadgil, Director and Chief Scientific Officer, Enzene Biosciences  Eric Fang, Chief Scientific Officer, Snapdragon Chemistry)  Ian Houson, Technical Project Manager, Continuous Manufacturing and Crystallization, University of Strathclyde Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    WWW.ROOTSANALYSIS.COM
    Continuous Manufacturing Market (Small Molecules and Biologics) | Industry Analysis | Market Size | 2030
    Market research report on pharmaceutical continuous manufacturing; with a focus on current landscape, key players and future growth opportunities
    0 Comments 0 Shares
  • Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market.

    Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers

    Roots Analysis is pleased to announce the publication of its recent study, titled, “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.”

    The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of HPAPIs and cytotoxic drugs. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. In addition to other elements, the study includes:
     A detailed assessment of the current market landscape of companies offering contract services for manufacturing HPAPIs and cytotoxic drugs.
     A competitiveness analysis of HPAPI and cytotoxic drugs contract manufacturers, featuring insightful representations.
     Detailed profiles of leading contract manufacturers of HPAPI and cytotoxic drugs (shortlisted on the basis of proprietary criterion).
     An analysis of the partnerships that have been established in this domain, in the recent past.
     An analysis of the various expansion initiatives undertaken by the players in this domain.
     An estimate of the overall, installed capacity for manufacturing HPAPIs and cytotoxic drugs based on data reported by industry stakeholders in the public domain.
     A qualitative analysis to decide whether to manufacture the potent products in-house or engage the services of a CMO.
     A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution.
     A case study on the antibody drug conjugates (ADCs) manufacturing market, highlighting a list of contract service providers and in-house manufacturers in this domain.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Type of Product
     HPAPIs
     Highly Potent Finished Dosage Forms

     Company Size
     Small-sized
     Mid-sized
     Large / Very Large

     Scale of Operation
     Preclinical / Clinical
     Commercial

     Type of Pharmacological Molecule
     Small Molecules
     Biologics

     Type of Highly Potent Finished Dosage Form
     Injectables
     Oral Solids
     Creams
     Others
     Key geographical regions
     North America
     Europe
     Asia Pacific
     Rest of the World

    The report includes detailed transcripts of discussions held with the following senior level representatives of stakeholder companies:
     Antonella Mancuso (Vice President and Chief Operating Officer, BSP Pharmaceuticals) and Maria Elena Guadagno (Business Director, BSP Pharmaceuticals)
     Klaus Hellerbrand (Managing Director, ProJect Pharmaceutics)
     Kevin Rosenthal (Business Head, Formulations and Finished Products, Alphora Research)
     Jennifer L Mitcham (Director, Business Development, Catalent Pharma Solutions) and Stacy McDonald (Group Product Manager, Catalent Pharma Solutions)
     Roberto Margarita (Business Development Director, CordenPharma)
     Allison Vavala (Senior Manager, Business Development, Helsinn)
     Mark Wright (Site Head, Piramal Healthcare)
     Javier E. Aznárez Araiz (Business Development Technician, Idifarma)

    Key companies covered in the report
     AbbVie Contract Manufacturing
     CARBOGEN AMCIS
     Catalent
     Evonik
     Formosa Laboratories
     Intas
     Lonza
     MabPlex
     Pfizer CentreOne

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/hpapi-and-cytotoxic-drugs-manufacturing/299.html

    Other Recent Offerings
    1. Antibody Contract Manufacturing Market, 2020 – 2030
    2. Cell Therapy Manufacturing Market (3rd Edition), 2019 – 2030
    3. Biopharma Contract Manufacturing Market (3rd Edition), 2019 – 2030



    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market. Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.” The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of HPAPIs and cytotoxic drugs. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. In addition to other elements, the study includes:  A detailed assessment of the current market landscape of companies offering contract services for manufacturing HPAPIs and cytotoxic drugs.  A competitiveness analysis of HPAPI and cytotoxic drugs contract manufacturers, featuring insightful representations.  Detailed profiles of leading contract manufacturers of HPAPI and cytotoxic drugs (shortlisted on the basis of proprietary criterion).  An analysis of the partnerships that have been established in this domain, in the recent past.  An analysis of the various expansion initiatives undertaken by the players in this domain.  An estimate of the overall, installed capacity for manufacturing HPAPIs and cytotoxic drugs based on data reported by industry stakeholders in the public domain.  A qualitative analysis to decide whether to manufacture the potent products in-house or engage the services of a CMO.  A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution.  A case study on the antibody drug conjugates (ADCs) manufacturing market, highlighting a list of contract service providers and in-house manufacturers in this domain.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Product  HPAPIs  Highly Potent Finished Dosage Forms  Company Size  Small-sized  Mid-sized  Large / Very Large  Scale of Operation  Preclinical / Clinical  Commercial  Type of Pharmacological Molecule  Small Molecules  Biologics  Type of Highly Potent Finished Dosage Form  Injectables  Oral Solids  Creams  Others  Key geographical regions  North America  Europe  Asia Pacific  Rest of the World The report includes detailed transcripts of discussions held with the following senior level representatives of stakeholder companies:  Antonella Mancuso (Vice President and Chief Operating Officer, BSP Pharmaceuticals) and Maria Elena Guadagno (Business Director, BSP Pharmaceuticals)  Klaus Hellerbrand (Managing Director, ProJect Pharmaceutics)  Kevin Rosenthal (Business Head, Formulations and Finished Products, Alphora Research)  Jennifer L Mitcham (Director, Business Development, Catalent Pharma Solutions) and Stacy McDonald (Group Product Manager, Catalent Pharma Solutions)  Roberto Margarita (Business Development Director, CordenPharma)  Allison Vavala (Senior Manager, Business Development, Helsinn)  Mark Wright (Site Head, Piramal Healthcare)  Javier E. Aznárez Araiz (Business Development Technician, Idifarma) Key companies covered in the report  AbbVie Contract Manufacturing  CARBOGEN AMCIS  Catalent  Evonik  Formosa Laboratories  Intas  Lonza  MabPlex  Pfizer CentreOne For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/hpapi-and-cytotoxic-drugs-manufacturing/299.html Other Recent Offerings 1. Antibody Contract Manufacturing Market, 2020 – 2030 2. Cell Therapy Manufacturing Market (3rd Edition), 2019 – 2030 3. Biopharma Contract Manufacturing Market (3rd Edition), 2019 – 2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis
    WWW.ROOTSANALYSIS.COM
    HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) | Industry Analysis | Market Size | 2030
    Market research report on the future of HPAPI and Cytotoxic drugs manufacturing, focus on current market landscape and future growth opportunities
    0 Comments 0 Shares

No results to show

No results to show

No results to show